Casaletto Lodigiano, Italy

Alberto Mazza

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Lodigiano, IT (2019)
  • Casaletto Lodigiano, IT (2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alberto Mazza: Innovator in Pharmaceutical Processes

Introduction

Alberto Mazza is a notable inventor based in Casaletto Lodigiano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of crisaborole, a medication used to treat certain skin conditions. With a total of 2 patents to his name, Mazza's work exemplifies innovation in drug formulation.

Latest Patents

Mazza's latest patents include a process for the preparation of crisaborole in a stable crystal form. This invention focuses on creating intermediates that enhance the stability and efficacy of the drug. Another significant patent is the process for the preparation of crisaborole itself, which outlines the methods for synthesizing this important pharmaceutical compound.

Career Highlights

Alberto Mazza is currently employed at Olon S.p.a., a company known for its commitment to pharmaceutical development and manufacturing. His role at Olon allows him to apply his expertise in innovative drug formulation processes, contributing to the advancement of medical treatments.

Collaborations

Mazza has collaborated with notable colleagues, including Federico Gassa and Lazzaro Feliciani. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.

Conclusion

Alberto Mazza's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an innovator. His work continues to impact the development of effective treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…